Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies.

Borot F, Wang H, Ma Y, Jafarov T, Raza A, Ali AM, Mukherjee S.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11978-11987. doi: 10.1073/pnas.1819992116. Epub 2019 May 28. Erratum in: Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14780-14781.

2.

Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback Loop.

Chen X, Deng H, Churchill MJ, Luchsinger LL, Du X, Chu TH, Friedman RA, Middelhoff M, Ding H, Tailor YH, Wang ALE, Liu H, Niu Z, Wang H, Jiang Z, Renders S, Ho SH, Shah SV, Tishchenko P, Chang W, Swayne TC, Munteanu L, Califano A, Takahashi R, Nagar KK, Renz BW, Worthley DL, Westphalen CB, Hayakawa Y, Asfaha S, Borot F, Lin CS, Snoeck HW, Mukherjee S, Wang TC.

Cell Stem Cell. 2017 Dec 7;21(6):747-760.e7. doi: 10.1016/j.stem.2017.11.003. Epub 2017 Nov 30.

3.

Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation.

Chhuon C, Pranke I, Borot F, Tondelier D, Lipecka J, Fritsch J, Chanson M, Edelman A, Ollero M, Guerrera IC.

Data Brief. 2016 Aug 20;9:51-6. doi: 10.1016/j.dib.2016.08.012. eCollection 2016 Dec.

4.

Changes in lipid raft proteome upon TNF-α stimulation of cystic fibrosis cells.

Chhuon C, Pranke I, Borot F, Tondelier D, Lipecka J, Fritsch J, Chanson M, Edelman A, Ollero M, Guerrera IC.

J Proteomics. 2016 Aug 11;145:246-253. doi: 10.1016/j.jprot.2016.07.003. Epub 2016 Jul 7.

PMID:
27397611
5.

Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Veit G, Avramescu RG, Perdomo D, Phuan PW, Bagdany M, Apaja PM, Borot F, Szollosi D, Wu YS, Finkbeiner WE, Hegedus T, Verkman AS, Lukacs GL.

Sci Transl Med. 2014 Jul 23;6(246):246ra97. doi: 10.1126/scitranslmed.3008889.

6.

DNMT3a mutations in high-risk myelodysplastic syndrome parallel those found in acute myeloid leukemia.

Ewalt M, Galili NG, Mumtaz M, Churchill M, Rivera S, Borot F, Raza A, Mukherjee S.

Blood Cancer J. 2011 Mar;1(3):e9. doi: 10.1038/bcj.2011.7. Epub 2011 Mar 11. No abstract available.

7.

Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice.

Dif F, Wu YZ, Burgel PR, Ollero M, Leduc D, Aarbiou J, Borot F, Garcia-Verdugo I, Martin C, Chignard M, Israel-Biet D, Kita Y, Scholte BJ, Touqui L.

Eur Respir J. 2010 Nov;36(5):1120-30. doi: 10.1183/09031936.00183409. Epub 2010 Apr 22.

8.

Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Borot F, Vieu DL, Faure G, Fritsch J, Colas J, Moriceau S, Baudouin-Legros M, Brouillard F, Ayala-Sanmartin J, Touqui L, Chanson M, Edelman A, Ollero M.

PLoS One. 2009 Oct 22;4(10):e7116. doi: 10.1371/journal.pone.0007116.

9.

CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion.

Dudez T, Borot F, Huang S, Kwak BR, Bacchetta M, Ollero M, Stanton BA, Chanson M.

Biochim Biophys Acta. 2008 May;1783(5):779-88. doi: 10.1016/j.bbamcr.2008.01.007. Epub 2008 Jan 18.

10.

Control of basal CFTR gene expression by bicarbonate-sensitive adenylyl cyclase in human pulmonary cells.

Baudouin-Legros M, Hamdaoui N, Borot F, Fritsch J, Ollero M, Planelles G, Edelman A.

Cell Physiol Biochem. 2008;21(1-3):75-86. doi: 10.1159/000113749. Epub 2008 Jan 16.

11.

Membrane cholesterol content modulates ClC-2 gating and sensitivity to oxidative stress.

Hinzpeter A, Fritsch J, Borot F, Trudel S, Vieu DL, Brouillard F, Baudouin-Legros M, Clain J, Edelman A, Ollero M.

J Biol Chem. 2007 Jan 26;282(4):2423-32. Epub 2006 Nov 15.

Supplemental Content

Support Center